The estimated Net Worth of Bobby Gaspar is at least $6.83 Milion dollars as of 1 April 2022. Dr Gaspar owns over 15,000 units of Orchard Therapeutics plc stock worth over $6,114,839 and over the last 5 years he sold ORTX stock worth over $0. In addition, he makes $712,410 as CEO i Member of Scientific Advisory Board & Exec. Director at Orchard Therapeutics plc.
Dr has made over 2 trades of the Orchard Therapeutics plc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 15,000 units of ORTX stock worth $11,100 on 1 April 2022.
The largest trade he's ever made was buying 15,000 units of Orchard Therapeutics plc stock on 1 April 2022 worth over $11,100. On average, Dr trades about 1,992 units every 76 days since 2020. As of 1 April 2022 he still owns at least 366,158 units of Orchard Therapeutics plc stock.
You can see the complete history of Dr Gaspar stock trades at the bottom of the page.
Dr. Bobby Gaspar Ph.D., M.D. is the CEO, Member of Scientific Advisory Board & Exec. Director at Orchard Therapeutics plc.
As the CEO i Member of Scientific Advisory Board & Exec. Director of Orchard Therapeutics plc, the total compensation of Dr D at Orchard Therapeutics plc is $712,410. There are no executives at Orchard Therapeutics plc getting paid more.
Dr D is 56, he's been the CEO i Member of Scientific Advisory Board & Exec. Director of Orchard Therapeutics plc since . There are no older and 1 younger executives at Orchard Therapeutics plc.
Bobby's mailing address filed with the SEC is C/O ORCHARD THERAPEUTICS PLC, 245 HAMMERSMITH ROAD, LONDON, X0, W6 8PW.
Over the last 5 years, insiders at Orchard Therapeutics plc have traded over $14,660,920 worth of Orchard Therapeutics plc stock and bought 794,017 units worth $3,579,149 . The most active insiders traders include Capital Management, L.P.Ra ..., Llc Fmr oraz Charles A Jr Rowland. On average, Orchard Therapeutics plc executives and independent directors trade stock every 116 days with the average trade being worth of $4,897,976. The most recent stock trade was executed by Frank E Thomas on 10 March 2023, trading 20,000 units of ORTX stock currently worth $9,200.
orchard therapeutics is dedicated to bringing transformative gene therapies to children with life-threatening orphan diseases. we work in partnership with the world’s most prestigious research centres to harness the life-giving potential of gene therapy. orchard’s leadership team and collaborators have more than a decade of experience in the development, manufacturing and commercialization of advanced therapies for orphan diseases. our mission is to provide the ideal environment and expertise to translate promising pre-clinical and early clinical results into commercially approved medicines available to patients around the world.
Orchard Therapeutics plc executives and other stock owners filed with the SEC include: